At the news
? NEUTRALIMPACT 3/10 6-K filed Nov 9, 2026 at 08:00 ET
Evaxion filed Amendment No. 1 to its F-1 registration statement and a related 6-K press release on November 9, 2026, to register for resale up to 38,450,000 ordinary shares (769,000 ADSs) issuable upon exercise of warrants held by the European Investment Bank (EIB) under a July 2025 debt settlement agreement. The company is not selling securities or receiving proceeds from the resale; it received a EUR 3.5 million debt cancellation in exchange for the warrants and may receive up to approximately $1.5 million if the warrants are exercised. The filing is a routine procedural step to fulfill registration rights granted to EIB, not a new capital raise.
- Evaxion filed Amendment No. 1 to Form F-1 (File No. 333-291685) on November 9, 2026, registering up to 38,450,000 ordinary shares (769,000 ADSs) for resale by EIB.
- The shares are issuable upon exercise of warrants issued to EIB under a July 11, 2025 debt settlement agreement, which cancelled EUR 3.5 million of a EUR 7 million loan.
- Evaxion is not selling any securities and will not receive proceeds from the resale; it may receive up to DKK 9,612,500 (approx. $1.5 million) if warrants are exercised.
- The warrants have an exercise price of DKK 0.25 per ordinary share, expire in ten years, and were issued at an effective conversion price of $4.87 per ADS (89% premium to market at the time).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access